What question did this study set out to answer?

To evaluate the safety and clinical efficacy of the Pipeline Embolization Device (PED) in treating large or giant intracranial internal carotid artery aneurysms, including lesions refractory to previous interventions.

February 16, 2013RadiologyOpen Access

Pipeline for Uncoilable or Failed Aneurysms: Results from a Multicenter Clinical Trial

View Full Paper

Ask AI

Bookmark

Authors

TBTibor BecskeRex Hospital DKDavid F. KallmesIslamic Azad University, Tehran ISIşıl SaatçiMemorial Ankara Hospital

Discussion

Member takes

Implication

Multicenter clinical trial demonstrates high occlusion rates with low adverse events for the Pipeline device in large intracranial aneurysms, indicating a safe treatment option.

Key Points

To evaluate the safety and clinical efficacy of the Pipeline Embolization Device (PED) in treating large or giant intracranial internal carotid artery aneurysms, including lesions refractory to previous interventions.
Conducted a multicenter clinical trial investigating the Pipeline Embolization Device (PED).
Evaluated patients presenting with large, giant, uncoilable, or previously failed intracranial internal carotid artery aneurysms.
Treatment with the Pipeline Embolization Device resulted in high rates of complete aneurysm occlusion.
The intervention demonstrated low rates of adverse neurological events, including among aneurysms that had failed previous alternative therapies.

Cite This Study

Becske et al. (2013) studied this question.

synapsesocial.com/papers/69d96f005e5bcb4e3b8366a8 https://doi.org/10.1148/radiol.13120099

View Full Paper

Ask AI

Bookmark

Implication

Multicenter clinical trial demonstrates high occlusion rates with low adverse events for the Pipeline device in large intracranial aneurysms, indicating a safe treatment option.

Pipeline for Uncoilable or Failed Aneurysms: Results from a Multicenter Clinical Trial

Discussion

Member takes

Implication

Key Points

Cite This Study

Pipeline for Uncoilable or Failed Aneurysms: Results from a Multicenter Clinical Trial

Discussion

Member takes

Implication

Key Points

Cite This Study

Also Consider

Also Consider